Figure 15. HRQoL: EQ5D scores at 5 year follow-up (all patients N stage 0, 65+, negative margins).

Figure 15HRQoL: EQ5D scores at 5 year follow-up (all patients N stage 0, 65+, negative margins)

From: Evidence reviews for breast radiotherapy

Cover of Evidence reviews for breast radiotherapy
Evidence reviews for breast radiotherapy: Early and locally advanced breast cancer: diagnosis and management: Evidence review H.
NICE Guideline, No. 101.
National Guideline Alliance (UK).
Copyright © NICE 2018.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.